Efficient delivery of NF-κB siRNA to human retinal pigment epithelial cells with hyperbranched cationic polysaccharide derivative-based nanoparticles

A hyperbranched cationic polysaccharide derivative-mediated small interfering (si)RNA interference strategy was proposed to inhibit nuclear transcription factor-kappa B (NF-κB) activation in human retinal pigment epithelial (hRPE) cells for the gene therapy of diabetic retinopathy. Two hyperbranched cationic polysaccharide derivatives containing the same amount of cationic residues, but with different branching structures and molecular weights, including 3-(dimethylamino)-1-propylamine-conjugated glycogen (DMAPA-Glyp) and amylopectin (DMAPA-Amp) derivatives, were developed for the efficient delivery of NF-κB siRNA into hRPE cells. The DMAPA-Glyp derivative showed lower toxicity against hRPE cells. Furthermore, the DMAPA-Glyp derivative more readily condensed siRNA and then formed the nanoparticles attributed to its higher branching architecture when compared to the DMAPA-Amp derivative. Both DMAPA-Glyp/siRNA and DMAPA-Amp/siRNA nanoparticles were able to protect siRNA from degradation by nuclease in 25% fetal bovine serum. The particle sizes of the DMAPA-Glyp/siRNA nanoparticles (70–120 nm) were smaller than those of the DMAPA-Amp/siRNA nanoparticles (130–180 nm) due to the higher branching architecture and lower molecular weight of the DMAPA-Glyp derivative. In addition, the zeta potentials of the DMAPA-Glyp/siRNA nanoparticles were higher than those of the DMAPA-Glyp/siRNA nanoparticles. As a result, siRNA was much more efficiently transferred into hRPE cells using the DMAPA-Glyp/siRNA nanoparticles rather than the DMAPA-Amp/siRNA nanoparticles. This led to significantly high levels of suppression on the expression levels of NF-κB p65 messenger RNA and protein in the cells transfected with DMAPA-Glyp/siRNA nanoparticles. This work provides a potential approach to promote hyperbranched polysaccharide derivatives as nonviral siRNA vectors for the inhibition of NF-κB activation in hRPE cells.

[1]  Jingnan Wang,et al.  An efficient nonviral gene-delivery vector based on hyperbranched cationic glycogen derivatives , 2014, International journal of nanomedicine.

[2]  Shannon M. Conley,et al.  A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium. , 2013, Biomaterials.

[3]  So Jin Lee,et al.  Structural modification of siRNA for efficient gene silencing. , 2013, Biotechnology advances.

[4]  Liqun Yang,et al.  Downregulation of VEGF mRNA expression by triamcinolone acetonide acetate-loaded chitosan derivative nanoparticles in human retinal pigment epithelial cells , 2012, International journal of nanomedicine.

[5]  Bing Yang,et al.  Hyperbranched cationic amylopectin derivatives for gene delivery. , 2012, Biomaterials.

[6]  R. Narain,et al.  Hyperbranched glycopolymers for blood biocompatibility. , 2012, Bioconjugate chemistry.

[7]  Noeris K. Salam,et al.  Lycium barbarum (Goji Berry) extracts and its taurine component inhibit PPAR-γ-dependent gene transcription in human retinal pigment epithelial cells: Possible implications for diabetic retinopathy treatment. , 2011, Biochemical pharmacology.

[8]  D. Chistiakov.  Diabetic retinopathy: pathogenic mechanisms and current treatments. , 2011, Diabetes & metabolic syndrome.

[9]  Gert Storm,et al.  Endosomal escape pathways for delivery of biologicals. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[10]  Hua Ai,et al.  The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. , 2011, Biomaterials.

[11]  K. Vårum,et al.  Effect of chitosan chain architecture on gene delivery: comparison of self-branched and linear chitosans. , 2011, Biomacromolecules.

[12]  A. Schachat,et al.  A review of clinical trials of anti-VEGF agents for diabetic retinopathy , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[13]  H. Gu,et al.  Synthesis and gene delivery of poly(amido amine)s with different branched architecture. , 2010, Biomacromolecules.

[14]  Xiao-tao Li,et al.  Nanofibrous polyhydroxyalkanoate matrices as cell growth supporting materials. , 2008, Biomaterials.

[15]  P. Colonna,et al.  Online determination of structural properties and observation of deviations from power law behavior. , 2008, Biomacromolecules.

[16]  L. T. Okano,et al.  Evaluation of amylopectin clusters and their interaction with nonionic surfactants. , 2007, Colloids and surfaces. B, Biointerfaces.

[17]  G. Peyman,et al.  Triamcinolone acetonide in ocular therapeutics. , 2007, Survey of ophthalmology.

[18]  P. Colonna,et al.  Branching features of amylopectins and glycogen determined by asymmetrical flow field flow fractionation coupled with multiangle laser light scattering. , 2007, Biomacromolecules.

[19]  Y. Lee,et al.  Effect of magnolol on TGF-beta1 and fibronectin expression in human retinal pigment epithelial cells under diabetic conditions. , 2007, European journal of pharmacology.

[20]  E. Fattal,et al.  Ocular delivery of nucleic acids: antisense oligonucleotides, aptamers and siRNA. , 2006, Advanced drug delivery reviews.

[21]  A. Buléon,et al.  Alpha-D-glucan-based dendritic nanoparticles prepared by in vitro enzymatic chain extension of glycogen. , 2006, Biomacromolecules.

[22]  D. Brown,et al.  SiRNA strategy against overexpression of extracellular matrix in diabetic retinopathy. , 2005, Experimental eye research.

[23]  T. Reineke,et al.  Hydroxyl stereochemistry and amine number within poly(glycoamidoamine)s affect intracellular DNA delivery. , 2005, Journal of the American Chemical Society.

[24]  D. Fischer,et al.  Copolymers of ethylene imine and N-(2-hydroxyethyl)-ethylene imine as tools to study effects of polymer structure on physicochemical and biological properties of DNA complexes. , 2002, Bioconjugate chemistry.

[25]  R. Frank.  Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. , 2002, American journal of ophthalmology.

[26]  V. V. van Hinsbergh,et al.  Hypoxia in combination with FGF-2 induces tube formation by human microvascular endothelial cells in a fibrin matrix: involvement of at least two signal transduction pathways. , 2001, Journal of cell science.

[27]  S. Yoshida,et al.  Role of NF-kappaB-mediated interleukin-8 expression in intraocular neovascularization. , 1998, Investigative ophthalmology & visual science.

[28]  M. Runge,et al.  Hypoxia Induces Cyclooxygenase-2 via the NF-κB p65 Transcription Factor in Human Vascular Endothelial Cells* , 1997, The Journal of Biological Chemistry.

[29]  Z. Gregor,et al.  Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. , 1994, The British journal of ophthalmology.

[30]  J. Folkman,et al.  Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. , 1993, Biochemical and biophysical research communications.

[31]  L. Ren,et al.  In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain , 2012, International Journal of Nanomedicine.

[32]  A. Müller,et al.  Performance of three PDMAEMA-based polycation architectures as gene delivery agents in comparison to linear and branched PEI , 2010 .

[33]  H. Uludaǧ,et al.  Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery. , 2009, Biomaterials.

[34]  Y. Changlong,et al.  NF-kappaBp65-specific siRNA inhibits expression of genes of COX-2, NOS-2 and MMP-9 in rat IL-1beta-induced and TNF-alpha-induced chondrocytes. , 2006, Osteoarthritis and cartilage.

[35]  M. Porta,et al.  Diabetic retinopathyA clinical update. , 2002, Diabetologia.